Ann: Immuron Aims to Secure FDA Approval for IMM-124E, page-5

  1. 928 Posts.
    lightbulb Created with Sketch. 61
    Really highlights the potential of Travelan. $100M in sales is very possible given that it's the only effective drug that prevents TD, and without any side effects. This company is just absurdly undervalued. I believe the company is worth at least 5X the current market cap alone solely based on the traveler's diarrhea indication.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
7.6¢
Change
0.002(2.70%)
Mkt cap ! $17.84M
Open High Low Value Volume
7.6¢ 7.7¢ 7.3¢ $68.99K 910.3K

Buyers (Bids)

No. Vol. Price($)
1 13800 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
7.6¢ 105548 1
View Market Depth
Last trade - 16.10pm 18/07/2025 (20 minute delay) ?
IMC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.